A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, positive controlled phase III study to evaluate the efficacy and
safety of BPI-7711 capsule in locally advanced or recurrent/metastatic treatment-naïve
non-small cell lung cancer patients with EGFR mutation